M. Solèr

2.3k total citations · 1 hit paper
33 papers, 1.8k citations indexed

About

M. Solèr is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, M. Solèr has authored 33 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 19 papers in Physiology and 8 papers in Immunology and Allergy. Recurrent topics in M. Solèr's work include Asthma and respiratory diseases (16 papers), Respiratory and Cough-Related Research (8 papers) and Allergic Rhinitis and Sensitization (8 papers). M. Solèr is often cited by papers focused on Asthma and respiratory diseases (16 papers), Respiratory and Cough-Related Research (8 papers) and Allergic Rhinitis and Sensitization (8 papers). M. Solèr collaborates with scholars based in Switzerland, United States and Germany. M. Solèr's co-authors include H. Fox, J. Thirlwell, Robert G. Townley, J S O′Brien, Jonathan Matz, Giovanni Della Cioppa, Roland Buhl, Niroo Gupta, M. Tamm and P Stulz and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Applied Physiology and Journal of Allergy and Clinical Immunology.

In The Last Decade

M. Solèr

33 papers receiving 1.7k citations

Hit Papers

The anti-IgE antibody omalizumab reduces exacerbations an... 2001 2026 2009 2017 2001 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
    2001 647 citations M. Solèr, Jonathan Matz et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Solèr Switzerland 16 1.2k 1.1k 578 175 153 33 1.8k
Alberto Pesci Italy 21 2.0k 1.7× 1.2k 1.1× 205 0.4× 315 1.8× 163 1.1× 51 2.6k
Gian Luca Casoni Italy 19 1.5k 1.3× 916 0.8× 88 0.2× 306 1.7× 172 1.1× 49 2.1k
Thomas C. Kotsimbos Australia 11 543 0.5× 449 0.4× 98 0.2× 93 0.5× 195 1.3× 12 926
Sabine Kony France 11 361 0.3× 419 0.4× 260 0.4× 67 0.4× 93 0.6× 14 907
Hayley L. Parker United Kingdom 6 425 0.4× 855 0.8× 127 0.2× 677 3.9× 61 0.4× 8 1.4k
William Monteiro United Kingdom 13 1.9k 1.7× 2.4k 2.2× 381 0.7× 496 2.8× 357 2.3× 20 2.7k
Charlene M. Prazma United States 12 1.1k 0.9× 1.5k 1.4× 318 0.6× 527 3.0× 353 2.3× 28 1.8k
John B. Hagan United States 19 338 0.3× 393 0.4× 492 0.9× 533 3.0× 213 1.4× 56 1.4k
Masayuki Hojo Japan 15 306 0.3× 279 0.3× 104 0.2× 154 0.9× 78 0.5× 103 840
Masahide Yasui Japan 22 739 0.6× 359 0.3× 38 0.1× 111 0.6× 269 1.8× 85 1.4k

Countries citing papers authored by M. Solèr

Since Specialization
Citations

This map shows the geographic impact of M. Solèr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Solèr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Solèr more than expected).

Fields of papers citing papers by M. Solèr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Solèr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Solèr. The network helps show where M. Solèr may publish in the future.

Co-authorship network of co-authors of M. Solèr

This figure shows the co-authorship network connecting the top 25 collaborators of M. Solèr. A scholar is included among the top collaborators of M. Solèr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Solèr. M. Solèr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Solèr, M., et al.. (2006). Double-Blind Study of OM-85 in Patients with Chronic Bronchitis or Mild Chronic Obstructive Pulmonary Disease. Respiration. 74(1). 26–32. 57 indexed citations
2.
Berger, William, Nancy K. Ostrom, M. Solèr, et al.. (2005). Omalizumab significantly reduces asthma exacerbations in patients with severe persistent asthma: A pooled analysis. Journal of Allergy and Clinical Immunology. 115(2). S75–S75. 2 indexed citations
3.
Solèr, M., et al.. (2003). Randomised Double-Blind Comparison of Oral Gatifloxacin and Co-amoxiclav for Acute Exacerbation of Chronic Bronchitis. European Journal of Clinical Microbiology & Infectious Diseases. 22(3). 144–150. 15 indexed citations
4.
Buhl, Roland, G. Hanf, M. Solèr, et al.. (2002). The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma. European Respiratory Journal. 20(5). 1088–1094. 124 indexed citations
5.
Buhl, Roland, M. Solèr, Jonathan Matz, et al.. (2002). Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma. European Respiratory Journal. 20(1). 73–78. 162 indexed citations
6.
Solèr, M.. (2001). OMALIZUMAB, A MONOCLONAL ANTIBODY AGAINST IgE FOR THE TREATMENT OF ALLERGIC DISEASES. International Journal of Clinical Practice. 55(7). 480–483. 7 indexed citations
7.
Schoenenberger, Ronald A., et al.. (2001). Severe bronchiolitis in acute Mycoplasma pneumoniae infection. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 439(6). 818–822. 11 indexed citations
8.
Solèr, M., Jonathan Matz, Robert G. Townley, et al.. (2001). The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. European Respiratory Journal. 18(2). 254–261. 647 indexed citations breakdown →
9.
Ullmer, Elke, M. Solèr, H Hamm, & André P. Perruchoud. (2000). Pathogenese, Diagnostik und Therapie der COPD. Pneumologie. 54(3). 123–132. 3 indexed citations
10.
Ullmer, Elke, Werner Strobel, & M. Solèr. (2000). Cheyne-Stokes Respiration or Obstructive Sleep Apnoea: Patterns of Desaturation. Respiration. 67(2). 203–203. 2 indexed citations
11.
Reichenberger, Frank, James Habicht, Peter Matt, et al.. (1999). Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplantation. 24(11). 1195–1199. 111 indexed citations
12.
Jordan, Peter J., et al.. (1996). Pulmonary function and exercise capacity after lung resection. European Respiratory Journal. 9(3). 415–421. 151 indexed citations
13.
Bolliger, Chris T., Peter J. Jordan, M. Solèr, et al.. (1995). Exercise Capacity as a Predictor of Postoperative Complications in Lung Resection Candidates. American Journal of Respiratory and Critical Care Medicine. 151(5). 1472–1480. 171 indexed citations
14.
Bolliger, Chris T., M. Solèr, P Stulz, et al.. (1994). Evaluation of High-Risk Lung Resection Candidates: Pulmonary Haemodynamics versus Exercise Testing. Respiration. 61(4). 181–186. 32 indexed citations
15.
Roth, Michael, et al.. (1992). Cell cultures from cryopreserved human lung tissue. Tissue and Cell. 24(4). 455–459. 21 indexed citations
16.
Weizman, Abraham, et al.. (1991). Airway effects of inhaled bradykinin, substance P, and neurokinin A in sheep. Journal of Allergy and Clinical Immunology. 87(2). 557–564. 30 indexed citations
17.
Solèr, M., François Michel, & André P. Perruchoud. (1991). Long-Term Oxygen Therapy for Cor Pulmonale in Patients with Chronic Obstructive Pulmonary Disease. Respiration. 58(1). 52–56. 2 indexed citations
18.
Solèr, M., et al.. (1990). PAF-induced airway responses in sheep: Effects of a PAF antagonist and nedocromil sodium. Journal of Allergy and Clinical Immunology. 85(3). 661–668. 8 indexed citations
19.
Solèr, M., M Sielczak, & William M. Abraham. (1990). A bradykinin-antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep. Pulmonary Pharmacology. 3(1). 9–15. 45 indexed citations
20.
Solèr, M., E. Imhof, & A Perruchoud. (1990). Severe Acute Asthma. Respiration. 57(2). 114–121. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Pesci Breakdown of academic impact, for papers by Gian Luca Casoni Breakdown of academic impact, for papers by Thomas C. Kotsimbos Breakdown of academic impact, for papers by Sabine Kony Breakdown of academic impact, for papers by Hayley L. Parker Breakdown of academic impact, for papers by William Monteiro Breakdown of academic impact, for papers by Charlene M. Prazma Breakdown of academic impact, for papers by John B. Hagan Breakdown of academic impact, for papers by Masayuki Hojo Breakdown of academic impact, for papers by Masahide Yasui
Rankless by CCL
2026